Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG-Guided vs Traditional Manual Lymphatic Drainage in Breast Cancer Patients
NCT06327490Phase 2Recruiting
- Sponsor
- University of Florida
- Start
- Oct 2024
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in breast cancer-related lymphedema (BCRL) (2 arms), sponsored by University of Florida. Primary endpoint: Subject compliance at 2 years. Started Oct 2024; status: recruiting.
02
Conditions
breast cancer-related lymphedema (BCRL)
Beyond the preview
Go deeper on NCT06327490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06327490.